Impact of GLP-1 receptor agonists on blood pressure, heart rate and hypertension among patients with type 2 diabetes: A systematic review and network meta-analysis
Top Cited Papers
- 13 August 2015
- journal article
- research article
- Published by Elsevier BV in Diabetes Research and Clinical Practice
- Vol. 110 (1), 26-37
- https://doi.org/10.1016/j.diabres.2015.07.015
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81302508)
- Research Fund for the Doctoral Program of Higher Education (20120001110015)
- Doctoral Fund of corps (2010JC15)
- National Key Technology R&D Program of China (2009BAI82B04)
This publication has 42 references indexed in Scilit:
- Blood pressure‐lowering effects of GLP‐1 receptor agonists exenatide and liraglutide: a meta‐analysis of clinical trialsDiabetes, Obesity and Metabolism, 2013
- Effects of exenatide and liraglutide on heart rate, blood pressure and body weight: systematic review and meta-analysisBMJ Open, 2013
- GLP-1 receptor agonists: A clinical perspective on cardiovascular effectsDiabetes and Vascular Disease Research, 2012
- Glucagon-like peptide-1 activates endothelial nitric oxide synthase in human umbilical vein endothelial cellsActa Pharmacologica Sinica, 2011
- Simultaneous comparison of multiple treatments: combining direct and indirect evidenceBMJ, 2005
- Combination of direct and indirect evidence in mixed treatment comparisonsStatistics in Medicine, 2004
- Bayesian Measures of Model Complexity and FitJournal of the Royal Statistical Society Series B: Statistical Methodology, 2002
- Quantifying heterogeneity in a meta-analysisStatistics in Medicine, 2002
- Assessing the quality of reports of randomized clinical trials: Is blinding necessary?Controlled Clinical Trials, 1996
- Heart rate and cardiovascular mortality: The Framingham studyAmerican Heart Journal, 1987